Stay updated on Biomarker Response to Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.2%
    Check dated 2025-01-12T20:42:32.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T23:04:41.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.
    Difference
    2%
    Check dated 2024-12-07T17:23:32.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The website has added a 'Show less' option, while several detailed data fields and download options related to clinical study information have been removed.
    Difference
    3%
    Check dated 2024-11-23T05:13:12.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    Several key health-related links have been removed, including those related to genetics, lung cancer, and clinical trials, which may impact access to important medical information.
    Difference
    0.4%
    Check dated 2024-11-16T00:34:26.000Z thumbnail image
  9. Check
    67 days ago
    Change Detected
    Summary
    The website has added several new resources related to lung cancer, including links to MedlinePlus and Dailymed, as well as updates to clinical trial documentation, while the previous revision (v2.12.1) has been removed.
    Difference
    4%
    Check dated 2024-11-08T18:44:19.000Z thumbnail image

Stay in the know with updates to Biomarker Response to Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page.